Loss of Pandion Therapeutics under GAAP in 6 months. In 2020, the loss was $15.657 million, up 36.3% from $11.49 million in the previous year. Revenue amounted to $3.956 million. During 6 months of 2019 the company did not receive any revenue.
Loss of Pandion Therapeutics under GAAP in 6 months. In 2020, the loss was $15.657 million, up 36.3% from $11.49 million in the previous year. Revenue amounted to $3.956 million. During 6 months of 2019 the company did not receive any revenue. 
investors.pandiontx.com
English (US) 